author-photo

Nicola Beltraminelli

26

Papers

277

Citations

Citation Trend

Filter By

Papers (23) Sort By

Journal Conference Others

Abstract 1882: Clinical approach and biomarker strategy for HFB301001, a novel OX40 agonistic antibody

2021 Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Attenuating nicotine's effects with high affinity human anti-nicotine monoclonal antibodies.

2021 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1843: Dicovery and characterization of a novel anti-human CXCR5 antibody for the treatment of B cell lymphomas

2021 Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1883: Mechanism of action and biomarker strategy for HFB200301, an anti-TNFR2 agonist antibody for the treatment of cancer

2021 Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1884: HFB9-2, a novel Galectin 9 neutralizing antibody for the treatment of AML and other cancers

2021 Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 2285: HFB10-1E1, a novel OX-40 agonistic antibody with a unique pharmacological profile and biomarker strategy

2020 Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 2282: Discovery and characterization of novel TNFR2 antibodies to modulate T cell activities in immunosuppressive environment

2020 Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 6532: HFB9-2: A novel Gal-9 neutralizing antibody to reverse immune suppression in the tumor microenvironment

2020
Show All
- Source
- Cite
- Save
Citations (0)
Deciphering the domain specificity of C. difficile toxin neutralizing antibodies

2019 Vaccine
Show All
- Source
- Cite
- Save
Citations (5)
transendothelial migration Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte

2013
Show All
- Source
- Cite
- Save
Citations (0)